“Best of” Second Annual Rheumatology Summit for Fellows: Optimizing Therapy While Reducing Risk
Rheumatology has seen rapid growth in both basic science and clinical understanding in recent years, much of which is inadequately addressed in medical training programs. There has also been an increase in the number of rheumatology fellowship programs to meet the increasing demand. To address gaps in knowledge and training in medical training programs regarding the management of patients with rheumatic disease, Vindico Medical Education held a day-long virtual educational activity for rheumatology fellows, led by an interdisciplinary panel of experts, addressing the treatment of patients with rheumatic disease as well as the management of associated complications and comorbidities. This “Best of” program provides highlighted presentations from that program.
Cost: FreeView Offer chevron_right
- Free; 1.5 AMA PRA Category 1 Credit(s)™
- The My Healio CME Dashboard keeps track of earned credits and saved activities
- Personalized recommendations make finding your next activity easy
- Over 50,000 of your colleagues know that earn credits is faster and easier with Healio CME
- Rheumatic disease
- rheumatoid arthritis (RA)
- psoriatic arthritis (PsA)
- spondyloarthritis (SpA)
- cardiovascular disease
- mental health disorders
Upon successful completion of this educational activity, participants should be better able to:
-Assess patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or spondyloarthritis (SpA) for disease activity, prognosis, and comorbidities, such as serious and opportunistic infections, cardiovascular disease, mental health disorders, and other complications.
-Apply the latest treat-to-target guideline approaches for the management of patients with RA, PsA, or SpA.
-Incorporate best practices for preventing and monitoring complications for patients with rheumatic disease, including risk profiling and vaccinations.
The intended audience for this activity is rheumatology fellows and other health care professionals involved in the treatment of patients with rheumatic diseases.
Additional credit info
This continuing medical education activity is provided by Vindico Medical Education
This activity is supported by educational grants from AbbVie Inc., Bristol-Myers Squibb, Celgene Corporation, and Novartis Pharmaceuticals Corporation.
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, November 17, 2020, to November 16, 2021.